A recent study conducted by FMI forecasts a remarkable growth trajectory for the Global Needle-Free Injectors Industry. Anticipated to surge at a staggering 12% CAGR between 2022 and 2032, the market is projected to reach a valuation of US$ 42.79 Billion by the end of the assessment period.
The driving force behind this growth is the demand for faster and more efficient drug delivery. With the healthcare sector on the rise and an increasing number of cosmetic surgeries, the demand for needle-free injectors is soaring. The industry has already witnessed significant growth, achieving a value CAGR of 8% from 2017 to 2021, culminating at US$ 12.3 Billion.
Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-13960
Geographically, US is the largest contributor to the Global Needle-Free Injectors Industry. This is owing to the growing prevalence of chronic diseases in the region. The strong presence of healthcare sectors in Germany, Japan and China too are accelerating the use of needle-free injectors. In the upcoming years, increasing inclination towards minimally invasive surgeries will increase the sales of needle-free injectors.
Key Takeaways from the Market Study
- By load type, the projectile injections segment is expected to expand at a CAGR of 13.9% during the forecast period.
- By technology, spring-loaded jet injector segment will dominate the market, holding 47.1% of the revenue share in 2022.
- By application, drug delivery is expected to hold the leading share in the market, accounting for 65.0% of the revenue share in 2022.
- With 79.5% of the revenue share, reusable needle-free injectors are expected to dominate the market in 2022
- By end-user, hospitals are expected to be the primary end-user, accounting for over 33.4% market share during the forecast period.
- US is expected to be a leading market across North America, accounting for over 94.0% of the market in 2022
- Germany is expected to dominate the Europe, holding 29.4% Europe’s market share through 2032
- Japan is projected to hold over 34% share in the East Asia market, exhibiting growth at a CAGR of 11.7% during the forecast period
- China led the East Asia market with more than 46.8% share and is projected to expand at a CAGR of 12.0% through 2032.
“The healthcare sector along with the cosmetic industry are the largest contributors to Global Needle-Free Injectors Industry. Increasing demand for minimally-invasive surgeries is further accelerating the demand for needle-free injectors” states an FMI analyst
Methodology Details Just a Click Away!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-13960
Market Competition
Key players in the needle-free injectors market are Gerresheimer AG, Pfizer Inc., Antares Pharma, CSL Limited (Seqirus UK Limited), Crossject, Portal Instruments, Ferring Pharmaceuticals, PharmaJet Inc., PenJet Corporation
- In August 2022, University of Adelaide began the human trail of omicron COVID vaccine booster using Pharma-Jet needle-free systems. In addition, the vaccines has been administered using PharmaJet Tropis NFIS.
- Portal Instruments, a key player in the needle-free injectors market is focusing on developing needle-free injectors for different chronic ailments and creating awareness regarding painless injections.
Key Segments Profiled In The Global Needle-Free Injectors Industry Industry Survey
Global Needle-Free Injectors Industry by Load:
- Needle-Free Injectors by Liquid Injections
- Needle-Free Injectors by Powder Injections
- Needle-Free Injectors by Projectile Injections
Global Needle-Free Injectors Industry by Technology:
- Needle-Free Injectors by Spring-loaded jet injector
- Needle-Free Injectors by Battery-powered jet injector
- Needle-Free Injectors by Gas-powered jet injector
Global Needle-Free Injectors Industry by Delivery Site:
- Needle-Free Injectors by Intra dermal injectors
- Needle-Free Injectors by Intramuscular injectors
- Needle-Free Injectors by Subcutaneous injectors
Global Needle-Free Injectors Industry by Application:
- Needle-Free Injectors by Drug Delivery
- Needle-Free Injectors by Vaccines
- Needle-Free Injectors by Cosmetic
- Needle-Free Injectors by Others
Global Needle-Free Injectors Industry by End User:
- Needle-Free Injectors by Home Care Settings
- Needle-Free Injectors by Long Term Care Centers
Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/13960
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube